CD11b+CD14+ BMMNCs improved hepatic fibrosis by reducing oxidative stress and inflammation in mouse models.[599] One clinical trial reported that injection of BMMNCs via the portal vein in decompensated hepatic fibrosis patients, but no significant efficacy was observed (NCT01120925). Here, ITGAM is linked to Hepatic fibrosis.